Phenylpiracetam (Phenotropil)
Phenylpiracetam (Phenotropil) scored 5.5 / 10 (⚖️ Neutral) on the BioHarmony scale as a Substance → Racetam.
Phenylpiracetam fits rare-use stimulant racetam scenarios; Nick's cited range is 100-200 mg in the morning, while Malykh 2010 supports only broad racetam context. Tolerance, sleep disruption, and athlete bans keep the score low.
What is Phenylpiracetam (Phenotropil)?
Phenylpiracetam (Phenotropil) scores 4.6/10 because its strongest case is stimulant-like cognition, reaction time, and environmental-stress tolerance, with weaker support outside that lane. The best read is practical and narrow: match the intervention to readers weighing a potent racetam against legality, sourcing, and sports-rule constraints.
The main evidence anchor is Malykh and Sadaie 2010. WADA Prohibited List adds important context, while PubChem Phenylpiracetam helps define the safety, sourcing, or regulatory caveat that keeps the score from moving higher.
The key caveat is that direct clinical evidence is thin, the compound is prohibited in sport, and gray-market sourcing raises trust issues. This report treats Phenylpiracetam as a candidate for specific use cases, not a general wellness shortcut.
Terminology
- Racetam: A family of synthetic nootropic compounds built on a shared pyrrolidone ring, of which phenylpiracetam is one of the more stimulating members.
- Phenotropil: The original Russian brand name for phenylpiracetam, the form most of the early human data was collected on.
- Dopaminergic: Acting on the dopamine system, which is tied to motivation, drive, and the alert, stimulant-like feel users report.
- AMPA: A glutamate receptor type involved in fast excitatory signaling and learning, one proposed target for racetam effects.
- NOAEL: No observed adverse effect level, the highest tested dose in a toxicology study that caused no measurable harm.
- WADA: The World Anti-Doping Agency, which lists phenylpiracetam as a banned stimulant, so tested athletes can fail a drug test using it.
- Tolerance: The drop in subjective effect that builds quickly with repeated phenylpiracetam use, which is why most people cycle it instead of dosing daily.
How do you take Phenylpiracetam (Phenotropil)?
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral | Capsule, powder, tablet, or food form depending on intervention | 100-200 mg, usually single-use or short cycles in anecdotal reports | 100-200 mg, usually single-use or short cycles in anecdotal reports |
Protocols
Conservative research comparison Mixed
- Dose
- 100-200 mg
- Frequency
- As studied or label-directed, with outcome tracking
- Duration
- Single session to 12 weeks depending on endpoint
Research-assistance framing only; avoid unsupervised escalation.
How this score is calculated →
What are the benefits of Phenylpiracetam (Phenotropil)?
Upside contribution: 2.12
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 3.5 | 0.875 | |
| Breadth | 15% | 3.0 | 0.450 | |
| Evidence | 25% | 3.0 | 0.750 | |
| Speed | 10% | 4.0 | 0.400 | |
| Durability | 10% | 2.2 | 0.220 | |
| Bioindividuality | 15% | 2.8 | 0.420 | |
| Total | 3.115 |
Upside Rationale
Phenylpiracetam (Phenotropil) upside is concentrated in stimulant-like cognition, reaction time, and environmental-stress tolerance. The rating credits a documented racetam-family record and clinical-use history rather than treating it as unproven, so it rewards the specific use cases while staying conservative about claims beyond them.
Efficacy (3.5/5.0): Phenylpiracetam earns this because the best signals map to stimulant-like cognition, reaction time, and stress tolerance, and the compound has a real clinical and athletic-use record. Malykh and Sadaie 2010 reviews the racetam-family human use that anchors the cognitive and stress-tolerance signal. The acute potency is notable, which is what lifts efficacy above the milder racetams.
Breadth of Benefits (3.0/5.0): Phenylpiracetam's benefits cluster in acute cognition, reaction time, and physical stress tolerance rather than spreading across unrelated systems, but within that lane the effect is credible. The report gives more credit where the evidence matches readers weighing a potent racetam against legality and sourcing, and less where endpoints drift into systems the pharmacology does not touch.
Evidence Quality (3.0/5.0): Phenylpiracetam has a documented clinical and real-world record, mostly older and from specific indications. Malykh and Sadaie 2010 reviews the human use and PubChem Phenylpiracetam documents the compound. Sample size and age of the literature keep this short of high certainty, but mechanism plus documented use supports a 3.0.
Speed of Onset (4.0/5.0): Phenylpiracetam is fast. Users typically notice stimulant-like focus and drive within an hour of dosing, which makes it easy to self-test. That rapid feedback is one of its defining features, though it does not replace longer safety follow-up.
Durability (2.2/5.0): Phenylpiracetam durability is moderate to low and tolerance builds quickly, so the benefit tracks intermittent dosing rather than a lasting carryover. The score rises only when the effect holds without dose escalation, which is uncommon with this compound.
Bioindividuality Upside (2.8/5.0): Phenylpiracetam response varies with baseline need, medications, caffeine response, sleep pressure, and tolerance. WADA Prohibited List is useful context for athletes, for whom the individual fit calculation is dominated by sport-testing rules.
What are the risks & downsides of Phenylpiracetam (Phenotropil)?
Downside contribution: 1.75 (safety risks weighted extra)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety | 30% | 2.3 | 0.690 | |
| Side effects | 15% | 2.6 | 0.390 | |
| Cost | 5% | 2.5 | 0.125 | |
| Effort | 5% | 1.6 | 0.080 | |
| Opportunity | 5% | 2.2 | 0.110 | |
| Dependency | 15% | 3.0 | 0.450 | |
| Reversibility | 25% | 1.8 | 0.450 | |
| Total | 2.295 | |||
| Harm subtotal × 1.4 | 2.772 | |||
| Opportunity subtotal × 1.0 | 0.315 | |||
| Combined downside | 3.087 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 1.747 |
Downside Rationale
Phenylpiracetam (Phenotropil) downside is the heaviest in this batch: it is prohibited in sport, tolerance builds fast, and gray-market sourcing raises trust issues. The risk score is highest where user selection, product quality, stimulant load, medical context, or regulation can change the expected result.
Safety risk (2.3/5.0): Phenylpiracetam carries more safety weight than the milder racetams because of its stimulant load and sleep-disruption potential, though it has no established fatality or organ-failure signal at sensible doses. Malykh and Sadaie 2010 anchors the human-use safety picture. Risk rises with high doses, late dosing, and stacking with other stimulants.
Side effect profile (2.6/5.0): Side effects matter more here: insomnia, overstimulation, irritability, and headache are common when dosed too high or too late. Malykh and Sadaie 2010 helps frame the cognitive benefit against this stimulant-driven tolerability burden. Most effects resolve by lowering dose and dosing early.
Financial cost (2.5/5.0): Cost is moderate. Beyond price per serving, the real spend is third-party COA testing for a gray-market compound plus the cost of chasing a tolerance-prone effect. Verified product matters more than the cheapest source.
Time / effort burden (1.6/5.0): Low to moderate. A measured dose once daily, but the fast tolerance means real effort goes into cycling discipline and avoiding daily use, plus verifying a trustworthy source.
Opportunity cost (2.2/5.0): Moderate. Phenylpiracetam can occupy a cognition slot that might go to sleep, training, caffeine management, or better-studied options, and its sport-prohibition makes it a non-starter for tested athletes who have cleaner alternatives.
Dependency / withdrawal (3.0/5.0): This is the standout downside. Tolerance builds quickly, so users tend to escalate dose or rely on it for performance, and stopping after regular use can bring a noticeable focus and energy dip. It is functional reliance plus fast tolerance rather than classic physiological addiction, but it is real enough to score higher than the other racetams.
Reversibility (1.8/5.0): Largely reversible. Effects and tolerance reset after a washout, and no permanent receptor, tissue, or gene-expression change is documented at typical doses. PubChem Phenylpiracetam supports the short-acting pharmacology that underlies the reset.
Is Phenylpiracetam (Phenotropil) worth it?
Phenylpiracetam is the most stimulating member of the racetam family, and it earns a middling score because the effect is real but narrow, fades fast with use, and rides on thin independent evidence plus a gray-market supply chain. It makes the most sense as an occasional tool for days you want sharper focus and physical drive at once, not as a daily cognitive base. The honest read is that the stimulant-like lift is the strongest part of the case, while broad long-term benefit stays unproven.
✅ Best for: People who want an occasional, morning-only focus and physical-performance boost, buy from a vendor with third-party purity testing, and accept that the effect fades quickly with repeated use. It fits best when you cycle it, take it early to protect sleep, and have a specific outcome in mind rather than vague all-day optimization.
❌ Avoid if: You are a drug-tested athlete (it is banned by WADA), you are stimulant-sensitive, pregnant, on conflicting medications, or you cannot verify your source. Avoid leaning on it daily or using it to paper over poor sleep, nutrition, or training, where better-studied basics will do more for less risk.
What is Phenylpiracetam (Phenotropil) best for?
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
Cognition / Focus: 5.2/10
Score: 5.2/10Phenylpiracetam scores 5.2/10 for cognition focus because the human or mechanistic literature points most directly at attention, focus, or cognitive-task performance. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays bounded by study size, replication, and how directly the endpoint maps to healthy-user goals. For readers, Phenylpiracetam is best interpreted as a focused use-case candidate, not a broad proof of benefit across unrelated systems. The score would move higher with independent replication, longer follow-up, and cleaner head-to-head comparisons against common alternatives.
Energy / Fatigue: 5.3/10
Score: 5.3/10Phenylpiracetam scores 5.3/10 for energy because the most plausible benefit is acute perceived energy or stimulant-like activation. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays bounded by study size, replication, and how directly the endpoint maps to healthy-user goals. For readers, Phenylpiracetam is best interpreted as a focused use-case candidate, not a broad proof of benefit across unrelated systems. The score would move higher with independent replication, longer follow-up, and cleaner head-to-head comparisons against common alternatives.
Reaction Time / Coordination: 5.0/10
Score: 5.0/10Phenylpiracetam scores 5.0/10 for reaction time because the reported benefit is most likely to show up on short-latency cognitive or performance tasks. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays bounded by study size, replication, and how directly the endpoint maps to healthy-user goals. For readers, Phenylpiracetam is best interpreted as a focused use-case candidate, not a broad proof of benefit across unrelated systems. The score would move higher with independent replication, longer follow-up, and cleaner head-to-head comparisons against common alternatives.
Cold / Heat Tolerance / Hormesis: 5.0/10
Score: 5.0/10Phenylpiracetam scores 5.0/10 for cold heat tolerance because the historical origin story and stimulant profile fit environmental-stress tolerance better than most other nonprimary goals. The strongest support comes from Malykh A. et al. 2010, but the practical rating stays bounded by study size, replication, and how directly the endpoint maps to healthy-user goals. For readers, Phenylpiracetam is best interpreted as a focused use-case candidate, not a broad proof of benefit across unrelated systems. The score would move higher with independent replication, longer follow-up, and cleaner head-to-head comparisons against common alternatives.
Frequently Asked Questions
What does phenylpiracetam actually feel like?
Phenylpiracetam feels closer to a clean stimulant than a subtle nootropic. Users report sharper focus, faster reaction time, more physical drive, and better tolerance for cold and fatigue. It was originally studied in stressed and cognitively impaired patients by Malykh 2010. In my own use the effects are strong the first few times, then fade fast, which is the main reason I keep it occasional rather than daily.
How much phenylpiracetam should I take?
Most people use 100 to 200 mg, and that is the range I run. I take it once in the morning so it does not wreck my sleep, and only on days I actually need it. Higher does not mean better here, because the effect plateaus and tolerance climbs fast. Do not stack it with other stimulants without a clear reason, and treat any dose above the common range as a separate risk decision.
Does phenylpiracetam cause tolerance?
Yes, and fast. The subjective lift drops noticeably after only a few days of consecutive use, which is one of the most consistent reports about this compound. That is exactly why I treat it as an occasional tool rather than a daily nootropic. Cycling it, with several days off between uses, keeps the effect meaningful. If you find yourself needing more to feel the same thing, that is your cue to stop, not to dose higher.
Is phenylpiracetam banned for athletes?
Yes. Phenylpiracetam is on the WADA Prohibited List as a stimulant, so any drug-tested athlete who uses it risks failing a test and a suspension. This is not a gray area. If you compete in any sport with anti-doping rules, this compound is a hard no. For everyone else it is a legal-status and sourcing question, but for tested athletes the answer is simply do not use it.
How strong is the human evidence for phenylpiracetam?
Thinner than the hype suggests. The most cited source is the review by Malykh 2010, which covers the racetam class across stroke, stress, and cognition, much of it from older Russian clinical work that has not been widely replicated by independent Western trials. So the cognition and stress-tolerance case is plausible and partly supported, but it is not the kind of large, repeated, independent evidence that earns a high score.
Will phenylpiracetam disrupt my sleep?
It can, because the effect is stimulant-like. That is why I only take it in the morning and never late in the day. If you dose it in the afternoon or evening you may find it harder to fall asleep, which then undercuts any cognitive benefit you were chasing. Sleep is the foundation everything else sits on, so if a focus aid costs you sleep it is a bad trade. Keep it early.
Is buying phenylpiracetam online safe?
Sourcing is one of the real risks here. Phenylpiracetam is sold in a gray market where products are not regulated like approved drugs, so identity, purity, and dose accuracy vary between vendors. PubChem can confirm what the molecule is, but it cannot vouch for what is actually in a given capsule. If you use it, buy from a vendor that publishes third-party purity testing, and treat unverified powders with real caution.
Should I use phenylpiracetam every day?
I would not, and I do not. Because tolerance builds so quickly, daily use mostly trades a fading benefit for ongoing stimulant exposure and possible sleep disruption. I use it on rare occasions when I want to push learning and physical performance at the same time, then stop. If you want a daily cognitive base, better-studied and lower-risk options make more sense, and phenylpiracetam stays as an occasional tool on top.
What could change Phenylpiracetam (Phenotropil)'s score?
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
Phenylpiracetam could move meaningfully if the evidence base changes because several current uncertainties are fixable. Independent trials could raise confidence, longer follow-up could clarify safety, and better product testing could reduce sourcing concern. Phenylpiracetam could also fall if larger studies fail to replicate the small positive findings, if regulatory scrutiny increases, or if real-world users report a pattern of sleep, mood, digestive, or cardiovascular problems. The scenarios below show how the same intervention can move across tiers without changing the scoring method, simply by improving or weakening the underlying facts.
| Scenario | Likely score |
|---|---|
| Larger independent human trials replicate the best outcome and safety stays clean. | 5.8 / 10 👍 Worth trying |
| Evidence stays mostly small, sponsor-linked, or disease-specific. | 4.6 / 10 ⚠️ Caution |
| New safety, sourcing, regulatory, or replication concerns appear. | 3.4 / 10 🚫 Skip |
BioHarmony Engine v2.0
Key Evidence Sources
- Malykh AG et al. 2010 - Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders, Drugs. Systematic review of piracetam-class nootropics across cognition, stroke, epilepsy, and stress, the main clinical anchor for phenylpiracetam's stimulant-like and cognitive claims.
- WADA 2026 Prohibited List. The World Anti-Doping Agency lists phenylpiracetam as a banned stimulant, so any drug-tested athlete risks a failed test by using it.
- PubChem compound record: Phenylpiracetam. Chemical identity and property database used to confirm what the molecule is, though it cannot verify the contents of any given commercial product.
- ClinicalTrials.gov registry. Registry of human trials checked for any registered phenylpiracetam studies, which underscores how little modern Western clinical work exists.
- PubMed biomedical literature database. Primary literature index used to search for human and mechanistic phenylpiracetam research beyond the main review.
- MedlinePlus drugs and supplements. Consumer health reference checked for any safety or interaction guidance on phenylpiracetam and related racetams.
What does the evidence say about Phenylpiracetam (Phenotropil)?
Evidence on this intervention is summarized across three complementary streams: contemporary clinical research, pre-RCT-era pharmacology and observational use, and the traditional medical systems that documented it first. Convergence across streams signals higher confidence; divergence is surfaced honestly.
Modern Clinical Research
Confidence: Low
Citations: Malykh 2010
Pre-RCT-Era Pharmacology and Use
Citations: Malykh 2010
Traditional Medicine Systems
Citations: Malykh 2010
What to Track If You Try This
These are the data points that matter most while running a 30-day Experiment with this intervention.
How to read this section
- Pre
- Test or score before starting the protocol. Anchors a baseline.
- During
- Track while running the protocol so you can see if anything is changing.
- Post
- Re-test after a full cycle to confirm the change held.
- Up
- The marker should rise. For most positive outcomes, that is a good sign.
- Down
- The marker should fall. For most positive outcomes, that is a good sign.
- Stable
- The marker should hold steady. Big swings in either direction are a yellow flag.
- Watch
- Direction depends on dose, timing, and your baseline. Pay close attention to the trend.
- N/A
- No expected direction. The entry is there to anchor a baseline reading.
- Primary
- The Pulse dimension most likely to shift. Track this first.
- Secondary
- Also relevant, but a smaller or less consistent shift. Track if Primary is unclear.
Bloodwork to Order
Open These Markers In Your Dashboard
- Blood Pressure Baseline (pre-protocol)
- Resting Heart Rate During | Expected Watch
- Sleep Duration During | Expected Down
Pulse Dimensions to Watch
- Energy During | Expected Up | Primary
- Drive During | Expected Up | Primary
- Sleep During | Expected Watch | Secondary
Subjective Signals (Daily Voice Card)
- Focus Intensity Scale 1-5 | During | Expected Up
- Irritability Scale 1-5 | During | Expected Watch
Red Flags: Stop and Consult
- Chest pain, palpitations, or severe anxiety
- Athlete exposure due to WADA prohibited status
Other interventions for Cognition & Focus
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. Tier bands: Skip 0–2.9, Caution 3.0–4.4, Neutral 4.5–5.7, Worth Trying 5.8–6.9, Strong Recommend 7.0–8.7, Top-tier 8.8–10.0.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 2.115 − 1.747 = 0.368
Formula v2.0 maps EV = 0 to score 5.0. Above neutral, EV = +4.00 reaches 10.0; below neutral, EV = −5.36 reaches 0.0. Both sides use the full 5-point half-scale.
Score = 5 + (0.368 / 4.00) × 5 = 5.5 / 10
Further learning
65+ Nootropic Ingredients I’ve Supplemented (Rated & Reviewed)
I've tested all kinds of nootropic ingredients & brain-boosting supplements. Here's a simple rundown, my personal ratings and mini review, and practical uses of…
Unconventional Ways to Power Up Your Brain & Perform Like an Elite Athlete
Did you know you could optimize your brain & body performance using nootropics safely & effectively? We discuss using substances like caffeine, dynamine &…
